Does Information on Blood Heavy Metals Improve Cardiovascular Mortality Prediction?
Xin Wang,Bhramar Mukherjee,Sung Kyun Park
DOI: https://doi.org/10.1161/JAHA.119.013571
IF: 6.106
2019-11-26
Journal of the American Heart Association
Abstract:Background To evaluate whether blood markers of lead, cadmium, and mercury can improve prediction for cardiovascular disease (CVD) mortality when added individually, jointly, or as an integrative index/Environmental Risk Score (ERS), in a model with established risk factors. Methods and Results Our study sample comprised 16 028 adults aged ≥40 years who were enrolled in the National Health and Nutrition Examination Survey 1999–2012 and followed up through December 31, 2015. The study sample was randomly split into training for the ERS construction (n=8043) and testing for the evaluation of prediction performance (n=7985). ERS was computed using elastic‐net penalized Cox's model based on the selected metal predictors predicting CVD mortality. During median follow‐up of 7.2 years, 517 died from CVD. In the training set, linear terms of cadmium and mercury, squared terms of lead and mercury, and all 3 pairwise interactions were selected by elastic‐net for ERS construction. In the testing set, the C‐statistic increased from 0.845 when only established CVD risk factors were in the model to 0.854 when the ERS was additionally added to the model. Addition of all linear, squared, and pairwise interaction terms of blood metals to the Cox's models improved C‐statistic from 0.845 to 0.857. The improvement remained significant when it was assessed by net reclassification improvement and integrated discrimination improvement. Conclusions Our findings suggest that blood markers of toxic metals can improve CVD risk prediction over the established risk factors and highlight their potential utility for CVD risk assessment, prevention, and precision health. Clinical Perspective What Is New? For the first time, the predictive value of blood markers of toxic metals, including lead, cadmium, and mercury, for cardiovascular disease mortality was assessed in a representative sample of US adults aged ≥40 years. Addition of multiple predictors of blood lead, cadmium, and mercury to the established risk factors significantly improved risk discrimination and risk reclassification of cardiovascular disease mortality. What Are the Clinical Implications? Assessment of blood toxic metals may be useful for identifying subpopulations that may benefit most from additional blood tests for predicting cardiovascular disease mortality. Our findings highlight a potential utility of assessment of exposure to environmental toxicants for cardiovascular disease risk assessment and prevention. Introduction Cardiovascular disease (CVD) remains the leading cause of death in the United States as well as globally. 1 , 2 Accurate assessment of CVD risk as an essential step toward disease prevention is an important public health goal. Scoring algorithms such as the Framingham Risk Score and the Pooled Cohort Equations (PCE) for the atherosclerotic CVD risk, 3 , 4 which combines the established risk factors, for example, systolic blood pressure, serum lipid levels, smoking, obesity, and diabetes mellitus, have been widely used for cardiovascular risk assessment in the general population. However, the accuracy of such algorithms has been questioned. 5 Attempts to improve risk prediction algorithms have been made by incorporating additional risk factors, including novel biomarkers, subclinical measures, and genetic variations. 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 However, the incremental information w -Abstract Truncated-
cardiac & cardiovascular systems